recombinant human vegf-a Search Results


human recombinant vegfa 165  (Proteintech)
93
Proteintech human recombinant vegfa 165
Human Recombinant Vegfa 165, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+vegf-a/Animal-free+Recombinant+Human+VEGF165/pmc09735515-40-0-7
Average 93 stars, based on 1 article reviews
human recombinant vegfa 165 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
humankine recombinant human vegf121 protein  (Proteintech)
92
Proteintech humankine recombinant human vegf121 protein
Humankine Recombinant Human Vegf121 Protein, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+vegf-a/Animal-free+Recombinant+Human+VEGF121/pmc12135391-48-0-6
Average 92 stars, based on 1 article reviews
humankine recombinant human vegf121 protein - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier
pksh033475 houston  (Elabscience Biotechnology)
90
Elabscience Biotechnology pksh033475 houston
Pksh033475 Houston, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+vegf-a/Recombinant+Human+VEGF165%2FVEGFA+Protein/pmc08123296-40-8-6
Average 90 stars, based on 1 article reviews
pksh033475 houston - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
reactivity  (Creative BioMart)
94
Creative BioMart reactivity
Reactivity, supplied by Creative BioMart, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+vegf-a/Recombinant+Human+VEGF165/pmc12988508-84-25-41
Average 94 stars, based on 1 article reviews
reactivity - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
recombinant orf virus vegf e  (Angio-Proteomie)
92
Angio-Proteomie recombinant orf virus vegf e
Recombinant Orf Virus Vegf E, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+vegf-a/Vascular+Endothelial+Growth+Factor+Human+Recombinant%2C+Baculovirus/10__1042_slash_bj20081013-40-0-7
Average 92 stars, based on 1 article reviews
recombinant orf virus vegf e - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier
pro-169 is a recombinant, humanized anti-vegf-a mab  (Genentech inc)
90
Genentech inc pro-169 is a recombinant, humanized anti-vegf-a mab
ERG analysis of NZW rabbits as a function of time after intravitreal injections. a The effects of the intravitreal <t>PRO-169</t> (white bars) and ranibizumab (dark bars) on the dark-adapted ERG responses after 30 days of each injection. The dark-adapted retinal response is represented by the mean ± SEM V Max ratio of the ERG (b-wave). b Time dependent effects of repeated injections of PRO-169 and ranibizumab on retinal function of rabbits. The difference of the log semi saturation constant (experimental-control) is represented by the mean ± SEM. V Max ratios are around 1 and log σ differences are around 0, indicating no damage to the road system
Pro 169 Is A Recombinant, Humanized Anti Vegf A Mab, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+vegf-a/pro+169+is+a+recombinant++humanized+anti+vegf+a+mab/pmc07389522-36-0-24
Average 90 stars, based on 1 article reviews
pro-169 is a recombinant, humanized anti-vegf-a mab - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
recombinant human vegfa-165  (AbCys s a)
90
AbCys s a recombinant human vegfa-165
ERG analysis of NZW rabbits as a function of time after intravitreal injections. a The effects of the intravitreal <t>PRO-169</t> (white bars) and ranibizumab (dark bars) on the dark-adapted ERG responses after 30 days of each injection. The dark-adapted retinal response is represented by the mean ± SEM V Max ratio of the ERG (b-wave). b Time dependent effects of repeated injections of PRO-169 and ranibizumab on retinal function of rabbits. The difference of the log semi saturation constant (experimental-control) is represented by the mean ± SEM. V Max ratios are around 1 and log σ differences are around 0, indicating no damage to the road system
Recombinant Human Vegfa 165, supplied by AbCys s a, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+vegf-a/recombinant+human+vegfa+165/pmc04699248-121-0-6
Average 90 stars, based on 1 article reviews
recombinant human vegfa-165 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
recombinant human vegf-a  (ApexBio)
90
ApexBio recombinant human vegf-a
ERG analysis of NZW rabbits as a function of time after intravitreal injections. a The effects of the intravitreal <t>PRO-169</t> (white bars) and ranibizumab (dark bars) on the dark-adapted ERG responses after 30 days of each injection. The dark-adapted retinal response is represented by the mean ± SEM V Max ratio of the ERG (b-wave). b Time dependent effects of repeated injections of PRO-169 and ranibizumab on retinal function of rabbits. The difference of the log semi saturation constant (experimental-control) is represented by the mean ± SEM. V Max ratios are around 1 and log σ differences are around 0, indicating no damage to the road system
Recombinant Human Vegf A, supplied by ApexBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+vegf-a/recombinant+human+vegf+a/pm39550364-32-80-84
Average 90 stars, based on 1 article reviews
recombinant human vegf-a - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
recombinant humanized vegf-a-specific monoclonal antibody bevacizumab  (Adamis corporation)
90
Adamis corporation recombinant humanized vegf-a-specific monoclonal antibody bevacizumab
ERG analysis of NZW rabbits as a function of time after intravitreal injections. a The effects of the intravitreal <t>PRO-169</t> (white bars) and ranibizumab (dark bars) on the dark-adapted ERG responses after 30 days of each injection. The dark-adapted retinal response is represented by the mean ± SEM V Max ratio of the ERG (b-wave). b Time dependent effects of repeated injections of PRO-169 and ranibizumab on retinal function of rabbits. The difference of the log semi saturation constant (experimental-control) is represented by the mean ± SEM. V Max ratios are around 1 and log σ differences are around 0, indicating no damage to the road system
Recombinant Humanized Vegf A Specific Monoclonal Antibody Bevacizumab, supplied by Adamis corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+vegf-a/recombinant+humanized+vegf+a+specific+monoclonal+antibody+bevacizumab/pmc07794000-168-14-40
Average 90 stars, based on 1 article reviews
recombinant humanized vegf-a-specific monoclonal antibody bevacizumab - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
vegf-a (human, recombinant antigen)  (Strathmann Biotec AG)
90
Strathmann Biotec AG vegf-a (human, recombinant antigen)
ERG analysis of NZW rabbits as a function of time after intravitreal injections. a The effects of the intravitreal <t>PRO-169</t> (white bars) and ranibizumab (dark bars) on the dark-adapted ERG responses after 30 days of each injection. The dark-adapted retinal response is represented by the mean ± SEM V Max ratio of the ERG (b-wave). b Time dependent effects of repeated injections of PRO-169 and ranibizumab on retinal function of rabbits. The difference of the log semi saturation constant (experimental-control) is represented by the mean ± SEM. V Max ratios are around 1 and log σ differences are around 0, indicating no damage to the road system
Vegf A (Human, Recombinant Antigen), supplied by Strathmann Biotec AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+vegf-a/vegf+a++human++recombinant+antigen+/10__3233_slash_ch___2010___1345-46-1-7
Average 90 stars, based on 1 article reviews
vegf-a (human, recombinant antigen) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
recombinant human vegf-a 165-amino acid isoform  (MBL International)
90
MBL International recombinant human vegf-a 165-amino acid isoform
ERG analysis of NZW rabbits as a function of time after intravitreal injections. a The effects of the intravitreal <t>PRO-169</t> (white bars) and ranibizumab (dark bars) on the dark-adapted ERG responses after 30 days of each injection. The dark-adapted retinal response is represented by the mean ± SEM V Max ratio of the ERG (b-wave). b Time dependent effects of repeated injections of PRO-169 and ranibizumab on retinal function of rabbits. The difference of the log semi saturation constant (experimental-control) is represented by the mean ± SEM. V Max ratios are around 1 and log σ differences are around 0, indicating no damage to the road system
Recombinant Human Vegf A 165 Amino Acid Isoform, supplied by MBL International, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+vegf-a/recombinant+human+vegf+a+165+amino+acid+isoform/pmc02791049-54-0-14
Average 90 stars, based on 1 article reviews
recombinant human vegf-a 165-amino acid isoform - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
biotinylated recombinant human vegf 165 protein, cf  (Bio-Techne corporation)
94
Bio-Techne corporation biotinylated recombinant human vegf 165 protein, cf
ERG analysis of NZW rabbits as a function of time after intravitreal injections. a The effects of the intravitreal <t>PRO-169</t> (white bars) and ranibizumab (dark bars) on the dark-adapted ERG responses after 30 days of each injection. The dark-adapted retinal response is represented by the mean ± SEM V Max ratio of the ERG (b-wave). b Time dependent effects of repeated injections of PRO-169 and ranibizumab on retinal function of rabbits. The difference of the log semi saturation constant (experimental-control) is represented by the mean ± SEM. V Max ratios are around 1 and log σ differences are around 0, indicating no damage to the road system
Biotinylated Recombinant Human Vegf 165 Protein, Cf, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+vegf-a/Biotinylated+Recombinant+Human+VEGF+165+Protein%2C+CF/bio-techne+corporation___bt10543
Average 94 stars, based on 1 article reviews
biotinylated recombinant human vegf 165 protein, cf - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

Image Search Results


ERG analysis of NZW rabbits as a function of time after intravitreal injections. a The effects of the intravitreal PRO-169 (white bars) and ranibizumab (dark bars) on the dark-adapted ERG responses after 30 days of each injection. The dark-adapted retinal response is represented by the mean ± SEM V Max ratio of the ERG (b-wave). b Time dependent effects of repeated injections of PRO-169 and ranibizumab on retinal function of rabbits. The difference of the log semi saturation constant (experimental-control) is represented by the mean ± SEM. V Max ratios are around 1 and log σ differences are around 0, indicating no damage to the road system

Journal: International Journal of Retina and Vitreous

Article Title: Safety and tolerability evaluation after repeated intravitreal injections of a humanized anti-VEGF-A monoclonal antibody (PRO-169) versus ranibizumab in New Zealand white rabbits

doi: 10.1186/s40942-020-00235-y

Figure Lengend Snippet: ERG analysis of NZW rabbits as a function of time after intravitreal injections. a The effects of the intravitreal PRO-169 (white bars) and ranibizumab (dark bars) on the dark-adapted ERG responses after 30 days of each injection. The dark-adapted retinal response is represented by the mean ± SEM V Max ratio of the ERG (b-wave). b Time dependent effects of repeated injections of PRO-169 and ranibizumab on retinal function of rabbits. The difference of the log semi saturation constant (experimental-control) is represented by the mean ± SEM. V Max ratios are around 1 and log σ differences are around 0, indicating no damage to the road system

Article Snippet: PRO-169 is a recombinant, humanized anti-VEGF-A mAb with a molecular mass of 149 kDa, structurally similar and with a target specificity like bevacizumab (Avastin, Genentech, South San Francisco, CA) [ , ].

Techniques: Injection

Histologic examination of the central retina for PRO-169 ( a ) vs ranibizumab ( b ) after the 1st Ivt injection (D32), for PRO-169 ( c ) vs ranibizumab ( d ) after the 2nd Ivt injection (D63), and for PRO-169 ( e ) vs ranibizumab ( f ) after the 3rd Ivt injection (D94). No retinal toxicity was found in any eyes (x40)

Journal: International Journal of Retina and Vitreous

Article Title: Safety and tolerability evaluation after repeated intravitreal injections of a humanized anti-VEGF-A monoclonal antibody (PRO-169) versus ranibizumab in New Zealand white rabbits

doi: 10.1186/s40942-020-00235-y

Figure Lengend Snippet: Histologic examination of the central retina for PRO-169 ( a ) vs ranibizumab ( b ) after the 1st Ivt injection (D32), for PRO-169 ( c ) vs ranibizumab ( d ) after the 2nd Ivt injection (D63), and for PRO-169 ( e ) vs ranibizumab ( f ) after the 3rd Ivt injection (D94). No retinal toxicity was found in any eyes (x40)

Article Snippet: PRO-169 is a recombinant, humanized anti-VEGF-A mAb with a molecular mass of 149 kDa, structurally similar and with a target specificity like bevacizumab (Avastin, Genentech, South San Francisco, CA) [ , ].

Techniques: Injection